New early phase trial for patients with recurrent glioblastoma

Mihaela Măncilă

A new clinical trial for patients with recurrent glioblastoma brain cancer has opened at UCLH, with leadership and support from researchers at UCL. The Phase I clinical trial, CITADEL-123, has been designed by Dr Paul Mulholland, Group Leader of Glioblastoma Research Group at the UCL Cancer Institute and UCLH consultant medical oncologist. It is open to patients who have had standard treatment, but who now have recurrent disease and are fit and well enough for treatment. Patients will undergo

New early phase trial for patients with recurrent glioblastoma https://www.ucl.ac.uk/ - 01.11.2024 07:26

din zilele anterioare

New early phase trial for patients with recurrent glioblastoma https://www.ucl.ac.uk/ - 01.11.2024 07:26